Inovio Pharmaceuticals Presents Immuno-Oncology Advancements … – Nasdaq
Weekly Register |
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements …
Nasdaq PLYMOUTH MEETING, Pa., Nov. 10, 2017– Inovio Pharmaceuticals, Inc. today announced that two of its cancer immunotherapies demonstrated. Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences What You Need to Know From Inovio Pharmaceuticals' Q3 Update Inovio Pharmaceuticals' (INO) CEO Dr. J. Joseph Kim on Q3 2017 Results – Earnings Call Transcript |
